472 related articles for article (PubMed ID: 17419758)
1. Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.
Ryan D; Drysdale AJ; Pertwee RG; Platt B
Eur J Neurosci; 2007 Apr; 25(7):2093-102. PubMed ID: 17419758
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB
Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ
Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells.
Drysdale AJ; Ryan D; Pertwee RG; Platt B
Neuropharmacology; 2006 Apr; 50(5):621-31. PubMed ID: 16386766
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.
Ohno-Shosaku T; Hashimotodani Y; Ano M; Takeda S; Tsubokawa H; Kano M
J Physiol; 2007 Oct; 584(Pt 2):407-18. PubMed ID: 17615096
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic suppression of excitation in murine autaptic hippocampal neurons.
Straiker A; Mackie K
J Physiol; 2007 Feb; 578(Pt 3):773-85. PubMed ID: 17110416
[TBL] [Abstract][Full Text] [Related]
6. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G
Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
[TBL] [Abstract][Full Text] [Related]
7. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
8. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
[TBL] [Abstract][Full Text] [Related]
9. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Moreira FA; Kaiser N; Monory K; Lutz B
Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
[TBL] [Abstract][Full Text] [Related]
10. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.
Osborne AL; Solowij N; Babic I; Lum JS; Newell KA; Huang XF; Weston-Green K
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109666. PubMed ID: 31202911
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404.
Hájos N; Kathuria S; Dinh T; Piomelli D; Freund TF
Eur J Neurosci; 2004 Jun; 19(11):2991-6. PubMed ID: 15182306
[TBL] [Abstract][Full Text] [Related]
13. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
[TBL] [Abstract][Full Text] [Related]
14. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.
Straiker A; Mackie K
J Physiol; 2005 Dec; 569(Pt 2):501-17. PubMed ID: 16179366
[TBL] [Abstract][Full Text] [Related]
15. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
16. Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages.
Jiang LS; Pu J; Han ZH; Hu LH; He B
Cardiovasc Res; 2009 Mar; 81(4):805-13. PubMed ID: 19074161
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates.
Butler RK; Rea K; Lang Y; Gavin AM; Finn DP
Pain; 2008 Dec; 140(3):491-500. PubMed ID: 19004548
[TBL] [Abstract][Full Text] [Related]
18. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus.
Di S; Boudaba C; Popescu IR; Weng FJ; Harris C; Marcheselli VL; Bazan NG; Tasker JG
J Physiol; 2005 Dec; 569(Pt 3):751-60. PubMed ID: 16239276
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons.
Straiker A; Dvorakova M; Zimmowitch A; Mackie K
Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714
[TBL] [Abstract][Full Text] [Related]
20. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
Wagner JA; Abesser M; Harvey-White J; Ertl G
J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
